[1] |
Kim JH, Park YM, Chin DK. Idiopathic hypertrophic spinal pachymeningitis: report of two cases and review of the literature[J]. J Korean Neurosurg Soc, 2011, 50(4): 392-395.
|
[2] |
Kupersmith MJ, Martin V, Heller G, et al. Idiopathic hypertrophic pachymeningitis[J]. Neurology, 2004, 62(5): 686-694.
|
[3] |
Misra UK, Kalita J. Idiopathic hypertrophic cranial pachymeningitis: easy to suspect, difficult to prove[J]. Neurology India,2002, 50(1): 4-5.
|
[4] |
Yonekawa T, Murai H, Utsuki S, et al. A nationwide survey of hypertrophic pachymeningitis in Japan[J]. J Neurol Neurosurg Psychiatry, 2013, 85(7): 732-739.
|
[5] |
Wang YJ, Fuh JL, Lirng JF, et al. Headache profile in patients with idiopathic hypertrophic cranial pachymeningitis[J]. Headache, 2010, 44(9): 916-923.
|
[6] |
Sakairi T, Sakurai N, Nakasatomi M, et al. Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients[J]. Scand J Rheumatol, 2018: 1-7.
|
[7] |
Okada M, Hato N, Okada Y. A case of hypertrophic cranial pachymeningitis associated with invasive aspergillus mastoiditis[J]. Auris Nasus Larynx, 2015, 42(6): 488-491.
|
[8] |
Joelson E, Ruthrauff B, Ali F, et al. Multifocal dural enhancement associated with temporal arteritis[J]. Arch Neurol, 2000, 57(1): 119-122.
|
[9] |
Muthukumar N, Senthilbabu S, Usharani K. Idiopathic hypertrophic cranial pachymeningitis masquerading as tolosa-hunt syndrome[J]. J Clin Neurosci, 2005, 12(5): 589-592.
|
[10] |
Lu LX, Della-Torre E, Stone JH, et al. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment[J]. JAMA Neurol, 2014, 71(6): 785-793.
|
[11] |
Just SA, Knudsen JB, Nielsen MK, et al. Wegener’s granulomatosis presenting with pachymeningitis: clinical and imaging remission by rituximab[J]. ISRN Rheumatol, 2011: 608942.
|
[12] |
Shi CH, Niu ST, Zhang ZQ. Clinical image and pathology of hypertrophic cranial pachymeningitis[J]. Genet Mol Res, 2014, 13(4): 10501-10509.
|
[13] |
Huang K, Xu Q, Ma Y, et al. Cerebral venous sinus thrombosis secondary to idiopathic hypertrophic cranial pachymeningitis: case report and review of literature[J]. World Neurosurg, 2017, 106: 1052.e13-1052.e21.
|
[14] |
Hahn LD, Fulbright R, Baehring JM. Hypertrophic pachymeningitis[J]. J Neurol Sci, 2016(367): 278-283.
|
[15] |
Jang Y, Lee ST, Jung KH, et al. Rituximab Treatment for idiopathic hypertrophic pachymeningitis[J]. J Clin Neurol, 2017, 13(2): 155-161.
|